Loading...
Welby Inc.
4438.T•JPX
Healthcare
Medical - Healthcare Information Services
¥353.00
¥-8.00(-2.22%)
Welby Inc. (4438.T) Financial Performance & Income Statement Overview
Review Welby Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-8.17%
↓ 8.17%
Operating Income Growth
-49.76%
↓ 49.76%
Net Income Growth
-59.33%
↓ 59.33%
Operating Cash Flow Growth
-246.91%
↓ 246.91%
Operating Margin
-125.91%
↓ 125.91%
Gross Margin
72.30%
↑ 72.30%
Net Profit Margin
-154.74%
↓ 154.74%
ROE
-88.11%
↓ 88.11%
ROIC
-100.51%
↓ 100.51%
Welby Inc. (4438.T) Income Statement & Financial Overview
Review Welby Inc.'s (4438.T) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $231.00M | $112.00M | $82.42M | $102.92M |
Cost of Revenue | $51.00M | $37.00M | $27.93M | $31.86M |
Gross Profit | $180.00M | $75.00M | $54.49M | $71.06M |
Gross Profit Ratio | $0.78 | $0.67 | $0.66 | $0.69 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $297.00M | $305.00M | $233.45M | $199.42M |
Operating Expenses | $298.00M | $304.00M | $233.45M | $199.42M |
Total Costs & Expenses | $349.00M | $341.00M | $261.38M | $231.28M |
Interest Income | $0.00 | $0.00 | $200000.00 | $3000.00 |
Interest Expense | $0.00 | $0.00 | $443000.00 | $161000.00 |
Depreciation & Amortization | $5.50M | $500000.00 | $967000.00 | $355000.00 |
EBITDA | -$111.50M | -$229.50M | -$177.73M | -$128.37M |
EBITDA Ratio | -$0.48 | -$2.05 | -$2.16 | -$1.25 |
Operating Income | -$118.00M | -$229.00M | -$178.96M | -$128.36M |
Operating Income Ratio | -$0.51 | -$2.04 | -$2.17 | -$1.25 |
Other Income/Expenses (Net) | -$162.00M | -$1.00M | -$186000.00 | -$531000.00 |
Income Before Tax | -$280.00M | -$230.00M | -$179.14M | -$128.89M |
Income Before Tax Ratio | -$1.21 | -$2.05 | -$2.17 | -$1.25 |
Income Tax Expense | $2.00M | $0.00 | $0.00 | -$1.91M |
Net Income | -$280.00M | -$221.00M | -$176.15M | -$126.98M |
Net Income Ratio | -$1.21 | -$1.97 | -$2.14 | -$1.23 |
EPS | -$33.86 | -$26.73 | -$22.49 | -$16.21 |
Diluted EPS | -$33.86 | -$26.73 | -$22.49 | -$16.21 |
Weighted Avg Shares Outstanding | $8.27M | $8.27M | $7.83M | $7.83M |
Weighted Avg Shares Outstanding (Diluted) | $8.27M | $8.27M | $7.83M | $7.83M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan